2022
DOI: 10.1245/s10434-022-11725-8
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of Second Primary Melanoma in Cutaneous Melanoma Survivors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 30 publications
1
10
0
Order By: Relevance
“…This phenomenon can be explained by the higher incidence of overall GC in older people, which thus dilutes the SIR of RGC. Similar ndings were also observed in second primary lung cancer, colorectal cancer, and melanoma (25)(26)(27). Moreover, it is possible that our result was supported by the multicentric carcinogenesis theory of MPGCs (9,28).…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…This phenomenon can be explained by the higher incidence of overall GC in older people, which thus dilutes the SIR of RGC. Similar ndings were also observed in second primary lung cancer, colorectal cancer, and melanoma (25)(26)(27). Moreover, it is possible that our result was supported by the multicentric carcinogenesis theory of MPGCs (9,28).…”
Section: Discussionsupporting
confidence: 87%
“…We also found that earlier year of diagnosis was associated with a signi cantly higher risk of developing RGC. Older age has been previously reported as independent risk factor for metachronous multiple cancers including RGC (9,(25)(26)(27), though this seemed counterintuitive because younger patients with FPGC have more time to develop RGC. Indeed, we did observe a higher SIR in younger patients compared with the general population (Fig.…”
Section: Discussionmentioning
confidence: 95%
“…Moreover, many of these studies combined in situ and invasive melanomas, 26 which made their results more vulnerable to bias due to overdiagnosis, increased patient awareness, and increased screening scrutiny in affected populations. 12 In contrast, we included only invasive second primary melanomas in our study to minimize the impact of overdiagnosis. Male sex and advancing age were independent factors associated with second primary melanoma in our study, which aligns with previous reports.…”
Section: Discussionmentioning
confidence: 99%
“…The steep increase in the incidence of cutaneous melanoma, along with larger numbers of melanomas being diagnosed at earlier stages, and improvements in melanoma treatment have resulted in an expanding population of melanoma survivors over the past decade . These patients are at risk of developing subsequent melanomas during their lifetime, although the reported risk of second primary melanoma from different studies varies substantially . Some previous studieswere limited to a single center, some combined in situ and invasive melanomas, and others included both synchronous (ie, second primary melanoma within the 30 days of their first diagnosis) and metachronous (ie, second primary melanoma after 30-day interval of their first diagnosis) primary melanomas.…”
Section: Introductionmentioning
confidence: 99%
“…Ferrone et al [32] USA 1996-2002 385/4484 (8.6%) 139 (36%) NR 2.3 Goggins et al [33] USA 1973-1997 1421/61 245 (2.3%) 313 (22%) NR NR Helgadottir et al [34] Sweden 1960-2004 44 2469/54 884 (4.5%) NR NR NR Hwa et al [35] USA 2002-2008 61/788 (7.7%) NR 7 NR Johnson et al [36] USA 1990-1995 60/1482 (4%) 18 (30%) 7 2.4 Kang et al [37] USA 1965-1989 41/2032 (2%) 16 (39%) 5 NR Lallas et al [38] Greece 2013-2018 46/977 (4.7%) NR 6 NR Manganoni et al [21] Italy 1996-2006 47/1240 (3.7%) 10 (21%) 10 2.4 Menzies et al [22] Ireland 1994-2016 99/2057 (4.8%) 6 (13%) 10 2.5 Moore et al [39] USA 1996-2011 1122/16 570 (6.7%) NR >4 NR Moseley et al [40] USA 1971-1979 38/712 (5.3%) 12 (31%) 8 NR Muller et al [41] Austria 1968-2015 48 299/1648 (18.1%) NR >4 NR Nashan et al [23] Germany NR 30/535 (5.6%) NR NR NR Nosrati et al [42] USA 1985-2013 305/7268 (4.2%) 68 (22%) 13 2.3 Palacios Diaz et al [43] Spain 2014-2022 58/646 (8.9%) 20 (34%) 5 2.2 Pastor-Tomas et al [14] Spain 2000-2015 55/1447 (3.8%) NR NR NR Savoia et al [19] Italy 1974-1997 49/2470 (2%) 21 (43%) 6 NR Scheibner et al [44] Australia 1951-1980 90/3128 (2.9%) Aprox. 33% 5 NR Schmid et al [45] Germany 1977-1992 152/4597 (3.3%) 58 (37%) NR NR Siskind et al [46] Australia 1982-1990 221/1083 (20.4%) 13 (5%) 9 NR Stam-Posthuma et al [13] Netherlands 1983-1995 56/820 (6.8%) 13 (23%) 9 2.8 Titus-Ernstoff et al [47] USA NR 27/354 (8.0%) 8 (29%) 3 2.1 Ungureanu et al [24] Romania 2004-2020 26/699 (3.7%) 13 (50%) 4 2.3 van der Leest et al [48] Netherlands 1989-2008 1840/57 465 (3.2%) NR NR NR Villani et al [49] Italy 2014-2018 64/773 (8.2%) NR 6 NR Wassberg et al [25] Sweden 1958-1988 243/20,354 (1.1%) NR NR NR Wiener et al [50] USA 1998-2012 5960/152,811 (3.9%) 1743 (29%) NR NR MPM = multiple primary melanomas, NR = not reported. www.md-journal.com…”
Section: Authormentioning
confidence: 99%